Silence's Cancer Rx Trial on Track as Firm Works out Milestones with Quark, Weighs Takeover Possibility

The previously announced buyout negotiations Silence is holding with an undisclosed party remain ongoing, but no new details were available.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories